SY-12882

N/A

Report date: 2025/01/26 15:50:46
NME

Base Information

Drug NameSY-12882
Drug Alias NameCDK12 inhibitors (Syros Pharmaceuticals)SY-12882
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 12 inhibitors
TargetsCyclin-dependent kinase 12
Therapy Area/IndicationsLung NeoplasmsOvarian NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesSyros Pharmaceuticals Inc
Inactive CompaniesDana-Farber Cancer Institute
Active IndicationsLung NeoplasmsOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A